Tasly Pharmaceutical Group Co Ltd (600535) — Tangible Net Worth Ratio
Tasly Pharmaceutical Group Co Ltd (600535) has a Tangible Net Worth Ratio of 84.1% as of June 2026. This metric is calculated by deducting intangible assets (CN¥2.10 Billion) from net assets (CN¥13.21 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 600535 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tasly Pharmaceutical Group Co Ltd Tangible Net Worth Ratio (1999–2025)
This chart shows how Tasly Pharmaceutical Group Co Ltd's Tangible Net Worth Ratio has changed across 27 annual periods from 1999 to 2025. As of June 2026, the ratio stands at 84.1%, reflecting net assets of CN¥13.21 Billion with intangible assets of CN¥2.10 Billion CNY. For live market cap and overall valuation, see how much is Tasly Pharmaceutical Group Co Ltd worth.
Annual Tangible Net Worth Ratio for Tasly Pharmaceutical Group Co Ltd (1999–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Tasly Pharmaceutical Group Co Ltd from 1999 to 2025, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 600535 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.2% | CN¥12.55 Billion | CN¥2.11 Billion | CN¥15.34 Billion | ▼ -4.8 pp |
| 2024 | 88.1% | CN¥12.11 Billion | CN¥1.45 Billion | CN¥14.98 Billion | ▲ +4.0 pp |
| 2023 | 84.0% | CN¥12.69 Billion | CN¥2.03 Billion | CN¥16.71 Billion | ▼ -3.4 pp |
| 2022 | 87.5% | CN¥12.63 Billion | CN¥1.58 Billion | CN¥16.43 Billion | ▼ -0.3 pp |
| 2021 | 87.8% | CN¥13.31 Billion | CN¥1.63 Billion | CN¥16.54 Billion | ▲ +1.1 pp |
| 2020 | 86.7% | CN¥12.38 Billion | CN¥1.65 Billion | CN¥16.49 Billion | ▲ +2.0 pp |
| 2019 | 84.7% | CN¥11.86 Billion | CN¥1.81 Billion | CN¥24.01 Billion | ▼ -1.3 pp |
| 2018 | 86.0% | CN¥11.21 Billion | CN¥1.56 Billion | CN¥25.17 Billion | ▼ -2.3 pp |
| 2017 | 88.3% | CN¥8.97 Billion | CN¥1.05 Billion | CN¥21.53 Billion | ▼ -0.2 pp |
| 2016 | 88.5% | CN¥8.21 Billion | CN¥939.78 Million | CN¥17.13 Billion | ▼ -0.6 pp |
| 2015 | 89.1% | CN¥7.71 Billion | CN¥840.12 Million | CN¥15.41 Billion | ▲ +2.5 pp |
| 2014 | 86.6% | CN¥5.07 Billion | CN¥680.50 Million | CN¥12.92 Billion | ▲ +0.5 pp |
| 2013 | 86.1% | CN¥4.14 Billion | CN¥577.99 Million | CN¥10.21 Billion | ▼ -5.2 pp |
| 2012 | 91.2% | CN¥4.21 Billion | CN¥368.33 Million | CN¥7.49 Billion | ▲ +1.0 pp |
| 2011 | 90.2% | CN¥3.78 Billion | CN¥369.18 Million | CN¥6.63 Billion | ▼ -0.9 pp |
| 2010 | 91.1% | CN¥3.42 Billion | CN¥305.49 Million | CN¥5.45 Billion | ▲ +4.8 pp |
| 2009 | 86.3% | CN¥2.17 Billion | CN¥298.00 Million | CN¥4.03 Billion | ▲ +3.3 pp |
| 2008 | 82.9% | CN¥2.09 Billion | CN¥357.38 Million | CN¥3.45 Billion | ▲ +0.3 pp |
| 2007 | 82.6% | CN¥1.97 Billion | CN¥343.46 Million | CN¥3.09 Billion | ▼ -12.6 pp |
| 2006 | 95.2% | CN¥1.72 Billion | CN¥82.41 Million | CN¥3.26 Billion | ▲ +0.9 pp |
| 2005 | 94.3% | CN¥1.56 Billion | CN¥88.96 Million | CN¥2.75 Billion | ▲ +1.6 pp |
| 2004 | 92.7% | CN¥1.37 Billion | CN¥100.28 Million | CN¥2.20 Billion | ▼ -3.6 pp |
| 2003 | 96.3% | CN¥1.20 Billion | CN¥43.94 Million | CN¥1.78 Billion | ▲ +1.4 pp |
| 2002 | 95.0% | CN¥997.00 Million | CN¥49.98 Million | CN¥1.25 Billion | ▲ +0.5 pp |
| 2001 | 94.5% | CN¥247.20 Million | CN¥13.55 Million | CN¥595.39 Million | ▲ +4.8 pp |
| 2000 | 89.7% | CN¥156.32 Million | CN¥16.07 Million | CN¥420.47 Million | ▲ +1.2 pp |
| 1999 | 88.5% | CN¥135.05 Million | CN¥15.56 Million | CN¥350.34 Million | — |